Aim: To describe anesthetic depth using spectal edge frequency (SEF) and density spectral array (DSA) and its relation to treatment effect of electroconvulsive therapy (ECT). Study design: Observational study Primary outcomes: SEF, DSA and treatment effect of ECT. Method: SEF and DSA si measured using a commercially available monitor for depth of anesthesia. Treatment effect of ECT will be evaluated using hemodynamic, electroencephalographic and clinical variables.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in spectral edge frequency
Timeframe: Monitored before, during and after ECT. Total monitoring time is apporximately 30 minutes per patient.
Change in density spectral array
Timeframe: Monitored before, during and after ECT. Total monitoring time is approximately 30 minutes per patient.
Duration of convulsive activity
Timeframe: Monitored immediately after administration of ECT.
Postictal supression
Timeframe: Monitored immediately after administration of ECT.
Need for restimulation
Timeframe: Monitored immediately after administration of ECT.
Change in heart rate.
Timeframe: Monitored immediately after administration of ECT.